Iradimed Corp. (IRMD) Tops Q2 EPS by 2c; Issues Confident Q3 Outlook, Boosts FY15 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 6/23/2026
- S&P 500, Nasdaq close lower, dragged by Alphabet and megacap tech; focus on Iran
- Oil settles down more 3% after US-Iran talks signal easing supply risks
- Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
- Alan Greenspan, influential former Federal Reserve chair, dies at 100
- Buy gold stocks as valuations are cheap amid macro tension: BofA
- Exclusive-China robot-hand-building unicorn Linkerbot targets $6 billion valuation
- Spain's ex-transport minister sentenced to 24 years for corruption
- Li Auto Inc. (LI) Breaks Ground on Chips R&D and Production Base
- China, US, UAE police arrest 276 telecom fraud suspects in Dubai
- Qtrex Quantum executives plan to buy up to 2M shares over 12 months
IRADIMED CORPORATION Announces Second Quarter 2015 Financial Results
July 30, 2015 7:30 AM EDTRevenue grows 62% compared to the same quarter last year Reports second quarter 2015 non-GAAP diluted EPS of $0.16 Increases full year 2015 revenue and non-GAAP earnings guidance Announces third quarter financial guidance
WINTER SPRINGS, Fla., July 30, 2015 (GLOBE NEWSWIRE) -- IRADIMED CORPORATION (NASDAQ: IRMD), the only known provider of non-magnetic intravenous (IV) infusion pump systems that are designed to be safe for use during magnetic resonance imaging (MRI) procedures, today announced financial results for the three months ended June 30, 2015.Â
For the second quarter ended June 30, 2015, the Company reported revenue of $7.6... More
